MK-3984
MK-3984 is a selective androgen receptor modulator that stimulates anabolic pathways in muscle and bone. MK-3984 can be used in research related to muscle wasting and related conditions.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 871325-55-2
- Fòrmula: C17H12F7NO2
- Peso molecular:395.27
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Actividad biológica
-
Chemical Information
- Protocolo
- Pureza y Documentación
- Referencias
-
Help & FAQs
Actividad biológica
Descripciòn
In Vitro
The androgen receptor (AR) is a ligand-dependent nuclear transcription factor that, upon binding androgens, translocates into the nucleus to regulate the transcription of target genes, mediating reproduction, tissue growth, and tumor cell proliferation.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
No. CAS 871325-55-2
-
Peso molecular 395.27
-
Fòrmula C17H12F7NO2
-
SMILES
FC(F)(F)C1=CC=C(F)C(CNC([C@](O)(C2=CC=CC=C2)C(F)(F)F)=O)=C1
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocolo
-
Research Protocol for Endocrine Diseases
Endocrine diseases often arise from disrupted hormone production, hormone signaling, or target-tissue responsiveness; for diabetes-focused endocrine disease models, insulin signaling regulates glucose uptake, hepatic glucose output, lipid metabolism, and β-cell compensation. Type 2 diabetes develops through interacting defects in insulin resistance, β-cell dysfunction, adipose inflammation, hepatic glucose overproduction, altered incretin signaling, and ectopic lipid metabolism. A major unresolved question is whether endocrine dysfunction is driven primarily by target-tissue insulin resistance, intrinsic β-cell failure, immune/inflammatory stress, or combined multi-organ failure that differs by disease stage.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
MK-3984 Related Classifications
HY-111246 Related Classifications
Powered by Bioz